A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma

[1]  M. Nagino,et al.  Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma , 2016, Journal of Gastroenterology.

[2]  Jung Hun Kang,et al.  D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy , 2015, Medicine.

[3]  Xiao-hui Liu,et al.  Pretreatment Plasma D-Dimer, Fibrinogen, and Platelet Levels Significantly Impact Prognosis in Patients With Epithelial Ovarian Cancer Independently of Venous Thromboembolism , 2015, International Journal of Gynecologic Cancer.

[4]  Yu-qin Pan,et al.  The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients , 2014, Medical Oncology.

[5]  O. Sanli,et al.  Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics. , 2014, Urologic oncology.

[6]  Murali Krishna Gurram,et al.  Effectiveness of D-Dimer as a Screening Test for Venous Thromboembolism: An Update , 2014, North American journal of medical sciences.

[7]  O. Thorlacius-Ussing,et al.  Prognostic value of preoperative d-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study , 2014, International Journal of Colorectal Disease.

[8]  H. Mollenkopf,et al.  Platelets Direct Monocyte Differentiation Into Epithelioid-Like Multinucleated Giant Foam Cells With Suppressive Capacity Upon Mycobacterial Stimulation , 2014, The Journal of infectious diseases.

[9]  Yanyan Li,et al.  Prognostic role of D-dimer in patients with lung cancer: a meta-analysis , 2014, Tumor Biology.

[10]  Zhong-min Yang,et al.  High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis , 2013, Tumor Biology.

[11]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[12]  S. Dourakis,et al.  Modern diagnostic approaches to cholangiocarcinoma. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.

[13]  S. Tsutsui,et al.  Plasma D-Dimer Level as a Mortality Predictor in Patients with Advanced or Recurrent Colorectal Cancer , 2012, Oncology.

[14]  J. Bridgewater,et al.  Review article: surgical, neo‐adjuvant and adjuvant management strategies in biliary tract cancer , 2011, Alimentary pharmacology & therapeutics.

[15]  M. Metcalfe,et al.  Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma , 2011, World Journal of Surgery.

[16]  L. Fink,et al.  Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer. , 2010, American journal of clinical pathology.

[17]  D. Talwar,et al.  The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study , 2010, British Journal of Cancer.

[18]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[19]  A. Nicholson,et al.  Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.

[20]  Shigemi Matsumoto,et al.  The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer , 2008, Oncology.

[21]  G. Lip,et al.  Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma , 2004, Thrombosis and Haemostasis.

[22]  J. Pollard,et al.  Role of infiltrated leucocytes in tumour growth and spread , 2004, British Journal of Cancer.

[23]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[24]  K. Oldhafer,et al.  Surgical treatment in proximal bile duct cancer. A single-center experience. , 1996, Annals of surgery.

[25]  V A Memoli,et al.  Pathways of Coagulation/Fibrinolysis Activation in Malignancy , 1992, Seminars in thrombosis and hemostasis.

[26]  L. Coussens,et al.  Inflammation and Cancer , 2016 .

[27]  J. Klempnauer,et al.  What constitutes long term survival after surgery for hilar cholangiocarcinoma? , 1997, Cancer.